CliffBio
small molecule

TRIAMCINOLONE ACETONIDE

TRIAMCINOLONE ACETONIDE

Loss of exclusivity—loss of exclusivity
CompanyCosette Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameTRIAMCINOLONE ACETONIDE
Active ingredientTRIAMCINOLONE ACETONIDE
Strength0.5%
Dosage formOINTMENT
RouteTOPICAL
ModalitySmall molecule
FDA approvalOctober 2017
Marketing statusDISCN

More from Cosette Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.